Torsten Georg Friedrich Buergermeister

Chief Financial Officer, Veraxa Biotech AG - Post de-SPAC.

Companies

Veraxa Biotech AG - Post de-SPACChief financial officer Jun 9, 2026 to Aug 20, 2026¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVeraxa Biotech AG - Post de-SPAC, Chief financial officer